An overview of the mechanisms of mutagenesis and carcinogenesis

Mutation Research - Reviews in Mutation Research

Volumn 544, Issue 2-3, 2003, Pages 99-106

  Sarasin, Alain ^a  

^a CNRS   (France)

Author keywords

Cancer; Clonal expansion; DNA repair; Mutations; Mutator phenotype; Translesion synthesis

Indexed keywords

AGE; APOPTOSIS; CANCER; CARCINOGENESIS; CELL CYCLE; CELL DIVISION; CELL MUTANT; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; DNA REPAIR; DNA REPLICATION; GENE AMPLIFICATION; GENE CONTROL; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; HYPOTHESIS; MICROENVIRONMENT; MOLECULAR CLONING; MOLECULAR MECHANICS; MUTAGENESIS; PHENOTYPE; POLYMERIZATION; PRIORITY JOURNAL; TUMOR CELL;

EID: 0345254979     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2003.06.024     Document Type: Conference Paper

References (36)

1. Peto R., Roe F.J., Lee P.N., Levy L., Clack J. Cancer and ageing in mice and men. Br. J. Cancer. 32:1975;411-426.
2. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10567-10570.
3. Loeb L.A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 54:1994;5059-5063.
4. Loeb L.A. A mutator phenotype in cancer. Cancer Res. 61:2001;3230-3239.
5. Loeb L.A., Loeb K.R., Anderson J.P. Multiple mutations and cancer. Proc. Natl. Acad. Sci. U.S.A. 100:2003;776-781.
6. DePinho R.A. The age of cancer. Nature. 408:2000;248-254.
7. Kumar S., Subramanian S. Mutation rates in mammalian genomes. Proc. Natl. Acad. Sci. U.S.A. 99:2002;803-808.
8. Luebeck E.G., Moolgavkar S.H. Multistage carcinogenesis and the incidence of colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 99:2002;15095-15100.
9. Marx J. Debate surges over the origins of genomic defects in cancer. Science. 297:2002;544-546.
10. Wang T.L., Rago C., Silliman N., Ptak J., Markowitz S., Willson J.K., Parmigiani G., Kinzler K.W., Vogelstein B., Velculescu V.E. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3076-3080.
11. Frank S.A., Nowak M.A. Cell biology: developmental predisposition to cancer. Nature. 422:2003;494.
12. Noonan F.P., Recio J.A., Takayama H., Duray P., Anver M.R., Rush W.L., De Fabo E.C., Merlino G. Neonatal sunburn and melanoma in mice. Nature. 413:2001;271-272.
13. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
14. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
15. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
16. Balaban G.B., Herlyn M., Clark W.H. Jr., Nowell P.C. Karyotypic evolution in human malignant melanoma. Cancer Genet. Cytogenet. 19:1986;113-122.
17. Sarasin A. The molecular pathways of ultraviolet-induced carcinogenesis. Mutat. Res. 428:1999;5-10.
18. Jacob S., Aguado M., Fallik D., Praz F. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res. 61:2001;6555-6562.
19. Shih I.M., Zhou W., Goodman S.N., Lengauer C., Kinzler K.W., Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 61:2001;818-822.
20. Zhou W., Goodman S.N., Galizia G., Lieto E., Ferraraccio F., Pignatelli C., Purdie C.A., Piris J., Morris R., Harrison D.J., Paty P.B., Culliford A., Romans K.E., Montgomery E.A., Choti M.A., Kinzler K.W., Vogelstein B. Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet. 359:2002;219-225.
21. Thiagalingam S., Laken S., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein B., Lengauer C. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 98:2001;2698-2702.
22. Goldsby R.E., Lawrence N.A., Hays L.E., Olmsted E.A., Chen X., Singh M., Preston B.D. Defective DNA polymerase-delta proofreading causes cancer susceptibility in mice. Nat. Med. 7:2001;638-639.
23. Srivastava D.K., Husain I., Arteaga C.L., Wilson S.H. DNA polymerase beta expression differences in selected human tumors and cell lines. Carcinogenesis. 20:1999;1049-1054.
24. Canitrot Y., Cazaux C., Frechet M., Bouayadi K., Lesca C., Salles B., Hoffmann J.S. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12586-12590.
25. Bergoglio V., Pillaire M.J., Lacroix-Triki M., Raynaud-Messina B., Canitrot Y., Bieth A., Gares M., Wright M., Delsol G., Loeb L.A., Cazaux C., Hoffmann J.S. Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res. 62:2002;3511-3514.
26. Jacob S., Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie. 84:2002;27-47.
27. Stary A., Sarasin A. The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie. 84:2002;49-60.
28. Giglia G., Dumaz N., Drougard C., Avril M.F., Daya-Grosjean L., Sarasin A. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res. 58:1998;4402-4409.
29. Giglia G., Bouffet E., Jouvet A., Ohgaki H., Kleihues P., Sarasin A. Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child. Int. J. Cancer. 81:1999;345-350.
30. Friedberg E.C., Wagner R., Radman M. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science. 296:2002;1627-1630.
31. Kannouche P., Broughton B.C., Volker M., Hanaoka F., Mullenders L.H., Lehmann A.R. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev. 15:2001;158-172.
32. Kannouche P., Fernandez de Henestrosa A.R., Coull B., Vidal A.E., Gray C., Zicha D., Woodgate R., Lehmann A.R. Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. EMBO J. 22:2003;1223-1233.
33. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 399:1999;700-704.
34. Stary A., Kannouche P., Lehmann A.R., Sarasin A. Role of DNA polymerase eta in the UV-mutation spectrum in human cells. J. Biol. Chem. 278:2003;18767-18775.
35. Benhamou S., Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat. Res. 462:2000;149-158.
36. Benhamou S., Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis. 17:2002;463-469.